Dr Reddy’s rolls out generic Allegra extended release tablets
The drug is indicated for the treatment of seasonal allergies such as itchy nose and sneezing. The launching of the drug follows the US Food and Drug Administration
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
Under the agreement, Icon will provide clinical pharmacology and exploratory clinical trial services including study conduct in Icon’s clinical pharmacology units, located in San Antonio, Texas; Omaha, Nebraska;